Explore UAB

Colleges & Schools

Lifespan Comprehensive Sickle Cell Center Heersink School of Medicine

Lifespan Comprehensive Sickle Cell Center

News

  • Love family pledges transformative $5 million gift to help improve care for patients with sickle cell disease, reduce disease-related complications
    This transformative gift from Ted W. Love, M.D., and Joyce Y. Love will improve patient care for those with sickle cell disease on a local and international level.
  • Understanding the applications of apheresis in treating various diseases
    The Transfusion Medicine Service in the UAB Department of Pathology performs therapeutic apheresis on patients who have an illness associated with an abnormal cellular or plasma-based blood component.
  • UAB is already a national leader in clinical trials. Here is how it plans to extend the benefits to even more Alabamians.
    Participating in a clinical trial can be lifesaving, and now, more patients than ever have access to life-changing therapies at UAB.
  • Gene therapy: What to know about the new FDA-approved treatment for sickle cell disease
    Sickle cell disease is the most common and clinically significant inherited blood disorder across the nation, and now there is an FDA-approved gene therapy to help those living with SCD.
  • UAB asks for public to consider regular blood donation
    UAB is joining the Red Cross in encouraging the public to donate blood now.
  • Kanter receives $7.7 million grant from the NIH to advance sickle cell disease research
    The NIH grant will advance efforts to reduce the gap between research and care of sickle cell disease.
  • New gene therapy could provide cure for sickle cell disease, according to UAB study
    Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.
  • Making the case to improve outcomes for sickle cell disease
    UAB’s Julie Kanter, M.D., says statewide surveillance programs for sickle cell disease can help facilitate progress to improve outcomes.
  • There is an urgent need for blood donation as blood supplies are dangerously low. Please encourage donation.
    Blood supplies have dropped to critically low levels at UAB.
  • ZAMBAMA grant leverages “reverse innovation” to reduce unhealthy alcohol use and improve HIV outcomes
    The collaboration puts UAB experts on the ground in Zambia to strengthen research and public health capacity and address major global health challenges.
  • Blood supplies are dangerously low. Please encourage donation.
    Blood supplies have dropped to critically low levels nationwide.
  • Blood supplies are low. Please encourage donation.
    Blood shortages are common in the summer months, and COVID-19 has played havoc with usual donation patterns.